Cytodyn Inc At This Drug is Now a Leading Contender to Treat COVID-19 Transcript
Joining me now is Nader Pourhassan. He's the CEO OF CytoDyne Inc, trading on the OTC under symbol, CYDY. Nader, welcome.
Thank you for having me. Thank you.
Questions & Answers
Nader, we're very interested to hear about your late stage leronlimab product, PRO 140, that is being explored for therapeutic indications associated with the COVID-19 virus. Can you tell us all about it, please?
So, we started with this product to develop it for HIV and when we were successful with our Phase 1, 2, and 3, we hit our primary endpoint and when FDA looked at it, it said you ready for your final application for final approval. [With] submitted one-third, FDA granted us rolling review. They had already given us fast track designation. So, two more section needs to be submitted before the approval
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
